Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade

Paula Ragan, CEO, X4 Pharmaceuticals presents Addressing Unmet Need in ccRCC Through Targeted CXCR4 Blockade at the 2016 annual International Kidney Cancer Symposium.